Skip to search.
 TSX Up 0.13% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
1.64 Down 0.02(0.91%) 3:29PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:1.66
Open:1.67
Bid:1.63 x 9100
Ask:1.64 x 4500
1y Target Est:6.00
Beta:1.41
Next Earnings Date:N/A
Day's Range:1.62 - 1.69
52wk Range:1.25 - 3.70
Volume:136,398
Avg Vol (3m):616,718
Market Cap:45.18M
P/E (ttm):N/A
EPS (ttm):-1.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Must Read

Comparison

Symbol% ChgMkt Cap
OPXADown 0.91%45.18M
SNYDown 0.09%140.91B
TEVADown 1.38%43.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.46
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback